×
NewGenIvf Group Common Stock Net 2023-2024 | NIVF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
NewGenIvf Group common stock net from 2023 to 2024. Common stock net can be defined as the value of common equity ownership.
View More
NewGenIvf Group Common Stock Net 2023-2024 | NIVF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
NewGenIvf Group common stock net from 2023 to 2024. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$146B
CVS Health (CVS)
$90.6B
Elevance Health (ELV)
$69.7B
Cencora (COR)
$58.8B
DiDi Global (DIDIY)
$29.4B
Labcorp Holdings (LH)
$23B
Natera (NTRA)
$22.2B
BioMerieux (BMXMF)
$17.5B
EUROFINS SCIENT (ERFSF)
$15.5B
ICON (ICLR)
$14.2B
Medpace Holdings (MEDP)
$12.7B
CochLear (CHEOY)
$12.7B
Solventum (SOLV)
$12.5B
Viatris (VTRS)
$12.5B
Caris Life Sciences,�Inc (CAI)
$10.7B
Revvity (RVTY)
$10.4B
Avantor (AVTR)
$8.6B
Sonic Healthcare (SKHHY)
$8B
HealthEquity (HQY)
$7.9B
Charles River Laboratories (CRL)
$7.6B
Bausch + Lomb (BLCO)
$5.1B
Sotera Health (SHC)
$4.5B
BrightSpring Health Services (BTSG)
$4.2B
KindlyMD (NAKA)
$4B
Amplifon S.p.A (AMFPF)
$3.9B
GeneDx Holdings (WGS)
$3.5B
Alignment Healthcare (ALHC)
$3.1B
Concentras Parent (CON)
$2.9B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.4B